The Biotic company obtains European financing to market the online legionella detection system

The biotechnology company Biotic Biochemistry Analytic SL located in the Scientific, Technological and Business Park of the Universitat Jaume I of Castellón (espaitec) has been one of the 14 Spanish companies that have accessed financing from the H2020 SME Instrument, which will invest in this second phase 73 million euros in 47 innovative SMEs.

Biotics It is the only company in the European biotechnology sector that has made the cut. Its objective is to develop and market an online detection and quantification system of Legionella spp in water (ULISENS). The firm is specialized in the development of rapid tests for the detection of pathogens in environmental samples with several products on the market, focused on the detection of Legionella, such as Legipid®Legionella Fast Detection.

The overall objective of the ULISENS (Ultra Legionella Immunoanalysis System for Early Sensing) project is to develop and subsequently market an automatic alert system capable of detecting and quantifying Legionella in water. The completely new system includes a rapid automatic detection module capable of carrying out real-time analysis on-site using information and communication technologies to minimise the time required to obtain results. This system is completely innovative as there is no technology on the market capable of carrying out an automated on-site analysis of Legionella present in an installation.

The European Commission has received 553 proposals to access the second phase, of which around 10% have been selected. Among all the selected projects, the Spanish ones stand out, with 14 SMEs of the 47 selected in fourteen countries that will receive a total of 15,4 million euros. Each project will receive up to 2,5 million euros (5 million in the case of health projects) to finance innovation, testing, piloting, scale-up and miniaturization activities, in addition to developing a mature business plan for its product.

The general objective of ULISENS (Ultra Legionella Immunoanalysis System for Early Sensing) project will be focused on the commercial development and further commercialization of an automatic early warning system capable of detecting and quantifying Legionella species in water. The system integrates an innovative fast detection automatic module capable of carrying out “in situ” analysis in real-time based on information and communication technologies to minimize the time for obtaining results. ULISENS will have the following functionalities:- Faster response time, with a time reduction of up to 99% compared with standard laboratory tests (1h vs 288h)- Greater reliability thanks to the certified detection and enumeration technology (accuracy of detection higher than 99% )- Lower cost, with reductions of up to 84% compared with standard laboratory tests – Direct sampling from user's network in real-time, no technical staff needed.- Sustainable detection biotechnology without maintenance – No hazardous waste generation (no biological waste)- Customizable online early warning module with internet connection to prevent users from risk.

Apart from the previous technological objectives, ULISENS has also the following specific objectives:- To develop a business and exploitation plan, including the assessment of the cost-effectiveness and exploitation potential of the solution. – To tackle main bottlenecks and barriers for the full commercialization of the innovative technologies, mainly related to legislative and regulatory aspects in each country.- To widely disseminate project outcomes to stakeholders and end-users, strengthening synergies with other initiatives and platforms to reach the maximum impact.- To analyze market and business strategies in the sector in order to find the best combination of external agents and international entities to develop cooperation strategies for market exploitation and further products commercialization.

The biotechnological company Biotic Biochemical Analytical SL located in the Scientific, Technological and Business Park of the Universitat Jaume I of Castelló (espaitec) has been one of the 14 Spanish companies that have accessed the financing of the Pime H2020 Instrument, which will invest in this second phase 73 million euros in 47 innovative SMEs.

Biotics It is the only company in the European biotechnology sector that has passed the test. The objective is to develop and commercialize an online detection and quantification system for Legionel spp in water (ULISENS). The firm (www.biotica.es) is specialized in the development of rapid tests for the detection of pathogens in environmental samples with various products on the market, focused on the first detection of Legionel·la, for example, Legipid® Legionel·la Fast Detection.

The general objective of the ULISENS project (Ultra Legionel·la Immunoanalysis System for Early Sensing) focuses on the development and subsequent commercialization of an automatic alert system capable of detecting and quantifying Legionella in the water. The system, completely new, integrates an automatic rapid detection module capable of performing "in situ" real-time analysis based on information and communication technologies to reduce the time it takes to obtain results to a minimum. This system is totally innovative since there is no technology on the market that is still capable of carrying out an automated on-site analysis of the Legion's presence in a facility.

The European Commission has received 553 proposals to access the second phase, of which 10% have been selected. Among all the selected projects, the Spanish ones stand out, with 14 of the 47 SMEs selected in fourteen countries that raise a total of 15,4 million euros. Each project will cost 2,5 million euros (5 million in the case of health projects) to finance innovation, testing, piloting, expansion and miniaturization activities, in addition to developing a mature business plan for the rest. producte.

 

WEBSITE FINANCED BY: